Developed by Ipswich Hospital NHS Trust and Ipswich and East Suffolk Clinical Commissioning Group. Joint formulary - Ophthalmology

Size: px
Start display at page:

Download "Developed by Ipswich Hospital NHS Trust and Ipswich and East Suffolk Clinical Commissioning Group. Joint formulary - Ophthalmology"

Transcription

1 Developed by Ipswich Hospital NHS Trust and Ipswich and East Suffolk Clinical Commissioning Group. Document type and title: Joint formulary - Ophthalmology Authorised document folder: New or replacing and existing document: Version number: 3.0 S:\Ipswich&East Suffolk CCG\Medicines Management\QIPP workstreams\joint formulary Replacing existing document Approving body: IESCCG Prescribing Workstream Ipswich Hospital Medicines Management Committee (IHT MMC) Date approved: IESCCG Prescribing Workstream: 05/05/15 IHT MMC: 08/05/15 Implementation date: 11/05/15 Author(s): Committee/ group/ individual responsible for updating this document Review date: July 2016 Medicines management pharmacist IESCCG and formulary pharmacist Ipswich Hospital Authors Revision History Version Date Initials Changes marked /2014 CB/RD N/A /2015 CB N/A /2015 CB Yes /2015 CB No Linked Documentation Document title Document file path Primary care formulary S:\Ipswich&East Suffolk CCG\Medicines Management\QIPP workstreams\primary care formulary work Ipswich Hospital Medicines Formulary Distribution Who to Via Date Version GP prescribing leads Workshare 01/ IHT MMC Meeting 01/ IHT formulary pharmacist 04/15 2.1

2 Joint formulary Prescriptions should be written generically unless a specific brand is recommended in the formulary below (will be shown in italics). Excipient intolerances should be included on the prescription If a preservative free eye preparation is required, please specify the rationale in the clinic letter/patient notes. Requests for preservative free products may be questioned if no rationale is provided. NB. The Ipswich Hospital pharmacy will substitute branded prescriptions for generic medication where it is available and more cost effective. Key Italics Most cost effective brand. (OTC) Item available to purchase over the counter from pharmacies and/or supermarkets Bold First choice based on available evidence and cost effectiveness Version: 3.0 Last updated: May 2015 Next review: July 2016 (or sooner if necessary) BNF section Drugs group Formulary Choices Notes 11 Eye Number of per bottle: Bottle size 2.5ml 5ml 10ml Approximate number of contained If patient has difficulty administering eye, consider co-prescribing an Opticare eye drop dispenser Unlicensed food supplements such as I-Caps etc. for age related macular degeneration should not be prescribed on the NHS Anti-infective eye preparations Antibacterials Chloramphenicol 0.5% eye (OTC) Chloramphenicol 1% eye ointment (OTC) Fucidic acid 1% gel Ciprofloxacin 0.3% eye Levofloxacin 0.5% eye Available OTC for patients over 2 years old Available OTC for patients over 2 years old Levofloxacin 0.5% preservative. free eye Antivirals Aciclovir 3% eye ointment 11.4 Corticosteroids and other anti-inflammatory preparations Corticosteroids Prednisolone 0.5% eye Betamethasone 0.1% eye/ear/nose (Vistamethasone ) Betamethasone 0.1% eye ointment Dexamethasone 0.1% eye (preservative free)

3 Other antiinflammatory preparations Fluorometholone eye (FML) Dexamethasone 0.1% single use eye (Dropodex ) Maxitrol eye Maxitrol eye ointment Rimexolone 1% eye Loteprenol eye Dexamethasone intravitreal Implant Fluocinolone acetonide intravitreal implant Sodium cromoglicate 2% eye (OTC) Nedocromil 2% eye Olopatadine 1mg/ml eye As per NICE TA229. As per NICE TA Mydriatics and cycloplegics Antimuscarinics Cyclopentolate 0.5% eye Cyclopentolate 1% eye Cyclopentolate 1% single use Tropicamide 1% single use Tropicamide 0.5% single use Atropine 1% eye Sympathomimetics Phenylephrine 2.5% single use 11.6 Treatment of glaucoma Phenylephrine 10% single use Beta-blockers Timolol 0.25% eye Prostaglandin analogues and prostamides Betaxolol 0.5% eye Timolol 0.1% unit dose eye (Tiopex ) Latanoprost 50mcg/ml eye Latanoprost preservative free eye (Monoprost ) Travoprost 40mcg/ml eye Bimatoprost 100mcg/ml. Reserved for or with poor compliance.. Reserved for.. Bimatoprost 300mcg/ml single. Reserved for use eye. Sympathomimetics Brimonidine 0.2% eye Carbonic anhydrase inhibitors and systemic drugs Dorzolamide 2% eye Brinzolamide 10mg/ml eye Acetazolamide tablets Acetazolamide injection. Reserved for patients intolerant of dorzolamide Hospital only Dorzolamide 2% unit dose eye. Reserved for Miotics Pilocarpine 1% eye Combination preparations Pilocarpine 2% eye Pilocarpine 2% single use Dorzolamide /timolol 2%/0.5% eye Latanoprost /timolol 50mcg/ml/0.5% eye

4 Brimonidine / Timolol 0.2%/0.5% eye Brinzolamide / timolol 10mg/ml/0.5% eye Bimatoprost / timolol 300mcg/ml/0.5% eye Travoprost /timolol 40mcg/ml/0.5% eye Dorzolamide /timolol 2%/0.5% single use eye 11.7 Local anaesthetics Oxybuprocaine 0.4% single use eye Proxymetacaine 0.5% single use eye Tetracaine 1% single use eye Lidocaine and fluorescein single use eye 11.8 Miscellaneous ophthalmic preparations Hypromellose 0.3% eye (OTC) Polyvinyl alcohol 1.4% eye (OTC) (Snotears ) Tear deficiency, ocular lubricants, and astringents Ocular diagnostic and peri-operative preparations and photodynamic treatment Carbomer % (OTC) Liquid paraffin eye ointment (OTC) Carmellose 1% single use eye (OTC) Carmellose 0.5% single use eye (OTC) Sodium chloride 5% preservative free eye / eye ointment [unlicensed special] Acetylcholine intra-ocular irrigation Aflibercept intravitreal injection Apraclonidine 0.5% eye Apraclonidine 1% single use eye Arceole Bevacizumab Injection Brilliant Peel Densiron 68 heavier-than-water endotamponade EasyGas C 2 F 6 pre-mixed syringes EasyGas C 3 F 8 pre-mixed syringes EasyGas SF6 pre-mixed syringes Fluorescein 1% singe use eye. Reserved for Clinitas Carbomer Gel eye is a cost effective brand Xailin Night is a cost effective brand. For night time use. Preservative free Melophthal is a cost effective brand. Each unit of Melophthal is re-sealable and may be used for up to 12 hours. Usual supply one box per month. Preservative free. Xailin Fresh 0.5% is a cost effective brand. Preservative free. As per NICE TA 294, TA305. Hospital use only. Various strengths. Only to be used when other agents not appropriate Off label special available from Moorfields.

5 Fluorescein 2% single use eye Flurbiprofen 0.03% eye Ketorolac 0.5% eye Ocriplasmin intrvitreal injection Ranibizumab intravitreal injection Vioron* As per NICE TA 297. Hospital only use As per NICE TA155, TA298, TA274, TA283. Joint formulary new drug requests Requests for new drugs from Ipswich Hospital (consultants only) please complete the Ipswich Hospital new drug submission form (available on hospital intranet) Requests for new drugs from primary care please complete the IESCCG new medication request form (available on the IESCCG website) Feedback Please send any feedback or comments to: Ipswich Hospital: Primary care:

BNF CHAPTER 11: EYE 1 January 2018

BNF CHAPTER 11: EYE 1 January 2018 BNF CHAPTER 11: EYE 1 BNF 11.3.1 ANTIBACTERIALS First Choice. Broad spectrum. Chloramphenicol 0.5% Eye Drops Administration Alternative Administration Eye drops, apply 1 drop at least every 2 hours then

More information

11.Eye Administration of drugs to the eye. Eye drops. Eye ointments. Prescribing of Unlicensed Eye Products

11.Eye Administration of drugs to the eye. Eye drops. Eye ointments. Prescribing of Unlicensed Eye Products 1 11.Eye 11.1 - Administration of drugs to the eye Eye-drop dispenser devices (Compleye, Opticare, Opticare Arthro 5, Opticare Arthro 10) are available to aid the instillation of eye drops from plastic

More information

11.Eye Administration of drugs to the eye. Eye drops. Eye ointments. Prescribing of Unlicensed Eye Products

11.Eye Administration of drugs to the eye. Eye drops. Eye ointments. Prescribing of Unlicensed Eye Products 1 11.Eye 11.1 - Administration of drugs to the eye Eye-drop dispenser devices (Compleye, Opticare, Opticare Arthro 5, Opticare Arthro 10) are available to aid the instillation of eye drops from plastic

More information

11 Eye. To be used in conjunction with NICE guidance/guidelines, the British National Formulary for adults and/or children, and

11 Eye. To be used in conjunction with NICE guidance/guidelines, the British National Formulary for adults and/or children, and 11 Eye To be used in conjunction with NICE guidance/guidelines, the British National Formulary for adults and/or children, and The Royal College of Ophthalmologists guidelines Index 11.1 Administration

More information

Ophthalmic Special Order Products, General Principles

Ophthalmic Special Order Products, General Principles Ophthalmic Special Order Products, General Principles When clinically appropriate and available, licensed products should always be prescribed and dispensed in preference to unlicensed products. Certain

More information

Ophthalmic Special Order Products, General Principles

Ophthalmic Special Order Products, General Principles Ophthalmic Special Order Products, General Principles When clinically appropriate and available, licensed products should always be prescribed and dispensed in preference to unlicensed products. Where

More information

Drugs That May Be Used by Certain Optometrists

Drugs That May Be Used by Certain Optometrists Drugs That May Be Used by Certain Optometrists Approved drugs. (a) Administration and prescription of pharmaceutical agents. Optometrists who are certified to prescribe and administer pharmaceutical agents

More information

South East London Area Prescribing Committee Chronic Open Angle Glaucoma and Ocular Hypertension Treatment Pathway

South East London Area Prescribing Committee Chronic Open Angle Glaucoma and Ocular Hypertension Treatment Pathway Proceed to 2 nd line treatment if further reduction in IOP required and there is good response to PGAs or (& no South East London Area Prescribing Committee Chronic Open Angle Glaucoma and Ocular Hypertension

More information

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC)

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) Guidelines for the medical treatment of chronic open angle glaucoma and ocular hypertension Summary: DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) Diagnosis and management of ocular hypertension (OHT)

More information

East and North Hertfordshire treatment pathway for primary open angle glaucoma and ocular hypertension in adults

East and North Hertfordshire treatment pathway for primary open angle glaucoma and ocular hypertension in adults East and North Hertfordshire treatment pathway for primary open angle glaucoma and ocular hypertension in adults Introduction Glaucoma is a group of eye diseases causing optic nerve damage. In most cases

More information

Volume 9; Number 6 May 2015 PRESCRIBING FOR CHRONIC OPEN ANGLE GLAUCOMA (COAG) AND OCULAR HYPERTENSION (OHT)

Volume 9; Number 6 May 2015 PRESCRIBING FOR CHRONIC OPEN ANGLE GLAUCOMA (COAG) AND OCULAR HYPERTENSION (OHT) Greater East Midlands Commissioning Support Unit in association with Lincolnshire Clinical Commissioning Groups, Lincolnshire Community Health Services, United Lincolnshire Hospitals Trust and Lincolnshire

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 28 May 2008

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 28 May 2008 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 28 May 2008 COSOPT 20 mg/5 mg/ml, eye drops, solution in single dose container Box of 60 0.2 ml single dose containers

More information

11 Eye. regarding this product in this setting. As a result we cannot recommend its use within NHSScotland.

11 Eye. regarding this product in this setting. As a result we cannot recommend its use within NHSScotland. Recommendations from the Lothian Formulary Committee (FC) following Scottish Medicines Consortium (SMC) advice, NICE MTA advice, (FAF3) unlicensed and off-label medicines and (FAF2) medicines not considered

More information

11 Eye. systemic disease or both eyes are affected (or 1 eye is affected if the second eye has poor visual acuity) and

11 Eye. systemic disease or both eyes are affected (or 1 eye is affected if the second eye has poor visual acuity) and Recommendations from the Lothian Formulary Committee (FC) following Scottish Medicines Consortium (SMC) advice, NICE MTA advice, (FAF3) unlicensed and off-label medicines and (FAF2) medicines not considered

More information

OCULAR PHARMACOLOGY GLAUCOMA. increased intraocular pressure. normally mm Hg. when to Tx no fixed level.

OCULAR PHARMACOLOGY GLAUCOMA. increased intraocular pressure. normally mm Hg. when to Tx no fixed level. OCULAR PHARMACOLOGY GLAUCOMA increased intraocular pressure normally 12 20 mm Hg. when to Tx no fixed level. literature sets ~21 mm Hg as upper limit of normal. some safe at 30 mm Hg some may have damage

More information

VI.2.2 Summary of treatment benefits

VI.2.2 Summary of treatment benefits EU-Risk Management Plan for Bimatoprost V01 aetiology), both OAG and ACG can be secondary conditions. Secondary glaucoma refers to any case in which another disorder (e.g. injury, inflammation, vascular

More information

A. Incorrect! Acetazolamide is a carbonic anhydrase inhibitor given orally or by intravenous injection.

A. Incorrect! Acetazolamide is a carbonic anhydrase inhibitor given orally or by intravenous injection. Pharmacology - Problem Drill 20: Drugs that Treat Glaucoma Question No. 1 of 10 1. is a topical carbonic anhydrase inhibitor. Question #01 (A) Acetazolamide (B) Clonidine (C) Dorzolamide (D) Apraclonidine

More information

CLINICAL OPHTHALMIC THERAPEUTIC PHARMACEUTICAL AGENTS (TPA) QUICK REFERENCE GUIDE

CLINICAL OPHTHALMIC THERAPEUTIC PHARMACEUTICAL AGENTS (TPA) QUICK REFERENCE GUIDE F- 15 CLINICAL OPHTHALMIC THERAPEUTIC PHARMACEUTICAL AGENTS (TPA) QUICK REFERENCE GUIDE Assembled by: Tim Maillet, OD, BSc NSAO Practice Innovations Committee Chairperson September 2009 F- 16 Ocular Allergies

More information

Elements for a Public Summary. Overview of disease epidemiology

Elements for a Public Summary. Overview of disease epidemiology VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Epidemiology of the disease Incidence and prevalence Increased pressure in the eye occurs in more than 100 million people, and

More information

DQSA Listening Session June 6, 2017

DQSA Listening Session June 6, 2017 DQSA Listening Session June 6, 2017 I am Allison Madson, manager of regulatory affairs, for the American Society of Cataract and Refractive Surgery. ASCRS is a medical specialty society representing nearly

More information

PATIENT CASE HISTORY. General Health Medications Allergies

PATIENT CASE HISTORY. General Health Medications Allergies OCULAR PHARMACOLOGY What I Need to Know Before I Medicate A Patient Lynn Lawrence, CPOT, ABOC, COA ROLE of the ASSISTANT AND TECHNICIAN Accurate documentation/recording Patient Education can assist in

More information

A Compendium of Product information & Indicative manufacturer s prices

A Compendium of Product information & Indicative manufacturer s prices A Compendium of Product information & Indicative manufacturer s prices (March 2012) for 28-days treatment with commonly used -free eye drops & ointments This information has been produced for prescribing

More information

ACETAZOLAMIDE (a-seet-a-zole-a-mide)

ACETAZOLAMIDE (a-seet-a-zole-a-mide) EYES Medicines for glaucoma Other medicines for glaucoma Active ingredients (generic names) ACETAZOLAMIDE (a-seet-a-zole-a-mide) Common brands include: Diamox, Glaumox What it is used for Acute glaucoma

More information

Dry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj.

Dry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj. Dry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj. 3-Ceftriaxone 250mg & Sulbactam 125mg Inj. 4-Ceftriaxone 125mg & Sulbactam 62.5mg Inj. 5-Rabeprazole

More information

BNF/BNFC Chapter 11 Eye

BNF/BNFC Chapter 11 Eye NF/NF hapter 11 ye irections for questions 1 to 8. ach of the questions or incomplete statements in this section is followed by five suggested answers. Select the best answer in each case. 1. Which of

More information

Chapter 12 Ear, Nose and Oropharynx

Chapter 12 Ear, Nose and Oropharynx Chapter 12 page number 1 Chapter 12 Ear, Nose and Oropharynx First line drugs Drugs recommended in both primary and secondary care Second line drugs Alternatives (often in specific conditions) in both

More information

Intravitreal Injection

Intravitreal Injection for patients Eye Clinic Ipswich Hospital Tel: 01473 703230 Intravitreal Injection What is an intravitreal injection? An intravitreal injection is the injection of a drug into the vitreous body (the jelly

More information

Long Term Care Formulary RS 14. RESTRICTED STATUS Topical Medical Treatment of Glaucoma 1 of 5

Long Term Care Formulary RS 14. RESTRICTED STATUS Topical Medical Treatment of Glaucoma 1 of 5 RESTRICTED STATUS Topical Medical Treatment of Glaucoma 1 of 5 PREAMBLE Significance: Glaucoma occurs in 1-2% of white people aged over 40 years, rising to 5% at 70 years and exponentially with advancing

More information

MECS and Prescribing. Jane Bell BSc FCOptom, DipTpIP, Dip Glauc

MECS and Prescribing. Jane Bell BSc FCOptom, DipTpIP, Dip Glauc MECS and Prescribing Jane Bell BSc FCOptom, DipTpIP, Dip Glauc Discussion House Rules Open discussion with everyone participating Respect the view of others; do not criticise or judge There are no right

More information

Writing a PBS-RPBS prescription authorised optometrists

Writing a PBS-RPBS prescription authorised optometrists Writing a PBS-RPBS prescription authorised optometrists www.medicareaustralia.gov.au Writing a PBS prescription authorised optometrists PBS items you are able to prescribe as an authorised optometrist

More information

REFERENCE GUIDE FOR OPHTHALMIC PREPARATIONS AVAILABLE FOR USE BY ALL OPTOMETRISTS*

REFERENCE GUIDE FOR OPHTHALMIC PREPARATIONS AVAILABLE FOR USE BY ALL OPTOMETRISTS* APPENDIX III REFERENCE GUIDE FOR OPHTHALMIC PREPARATIONS AVAILABLE FOR USE BY ALL OPTOMETRISTS* *Excluding preparations for use in the treatment of dry eye 1 Antazoline Sulphate (P) For the temporary relief

More information

Abbreviated Update: Ophthalmic Glaucoma Agents

Abbreviated Update: Ophthalmic Glaucoma Agents Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-945-5220 Fax 503-947-1119 Abbreviated Update: Ophthalmic Glaucoma Agents Month/Year

More information

Data from the recent therapeutic

Data from the recent therapeutic Getting started in therapeutics Part 8a What drugs will I prescribe and supply? Continuing our series on therapeutics in practice, Lucy Titcomb and Professor John Lawrenson review the range of ophthalmic

More information

Medical Treatment in Pediatric Glaucoma

Medical Treatment in Pediatric Glaucoma Medical Treatment in Pediatric Glaucoma By Nader Bayoumi, MD Lecturer of Ophthalmology Ophthalmology Department Alexandria University Alexandria, Egypt ESG 2012 Pediatric glaucoma is a surgical disease

More information

TA Number. TA Link. Annotation

TA Number. TA Link. Annotation Report generated from BNF with QVH Formulary provided by FormularyComplete (www.pharmpress.com). Accessed 09 10 2015 Title Formulary Status Section TA Number TA Link Annotation Almond Oil 12.1 Drugs acting

More information

Miotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D.

Miotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D. Miotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D. Direct agonists Indirect agonist Antagonist Direct agonist: Miosis, accomodation

More information

4/24/2018. Miotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D.

4/24/2018. Miotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D. Miotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D. Direct agonists Indirect agonist Antagonist Direct agonist: Miosis, accomodation Increase

More information

OPHTHALMIC MEDICATIONS

OPHTHALMIC MEDICATIONS OPHTHALMIC MEDICATIONS Ally Cuddy, PharmD PGY1 Pharmacy Resident September 7, 2017 AMERICAN ACADEMY OF OPHTHALMOLOGY American Academy of Ophthalmology. 2015. CASE #1 TR is a 76 YOM with no significant

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health Technology Appraisal. Aflibercept for treating diabetic macular oedema.

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health Technology Appraisal. Aflibercept for treating diabetic macular oedema. NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Health Technology Appraisal Aflibercept for treating diabetic macular oedema Final scope Final remit/appraisal objective To appraise the clinical and cost

More information

Martindale Pharma is a UK pharmaceutical manufacturing company supplying niche products to over 50 countries worldwide.

Martindale Pharma is a UK pharmaceutical manufacturing company supplying niche products to over 50 countries worldwide. INTERNATIONAL Martindale Pharma is a UK pharmaceutical manufacturing company supplying niche products to over 50 countries worldwide. Our vision Making Lives Better drives every action and decision of

More information

OPR OPTOMETRIC PRACTICE REFERENCE STANDARDS OF PRACTICE

OPR OPTOMETRIC PRACTICE REFERENCE STANDARDS OF PRACTICE OPR OPTOMETRIC PRACTICE REFERENCE The best eye health and vision for everyone in Ontario, through excellence in optometric care. Publishing History The Guide to the Clinical Practice of Optometry FIRST

More information

2019 Catalog Hospital and Ophthalmology Products and Services

2019 Catalog Hospital and Ophthalmology Products and Services 209 Catalog Hospital and Ophthalmology Products and Services Ophthalmology Ophthalmology Services. No prescription required No minimum order quantity New formulations are continually added to our portfolio.

More information

Chapter 12 Ear, Nose and Oropharynx

Chapter 12 Ear, Nose and Oropharynx Chapter 12 page number 1 Chapter 12 Ear, Nose and Oropharynx First line drugs Drugs recommended in both primary and secondary care Second line drugs Alternatives (often in specific conditions) in both

More information

Purpose of the Guideline

Purpose of the Guideline Trust Policy and Procedure Substitution of Medicines Policy Document ref. no: PP(17)210 For use in: For use by: For use for: Document owner: Status: All clinical areas Pharmacists and authorised Pharmacy

More information

Treatments for Open-Angle Glaucoma. A Review of the Research for Adults

Treatments for Open-Angle Glaucoma. A Review of the Research for Adults Treatments for Open-Angle Glaucoma A Review of the Research for Adults Is This Information Right for Me? Yes, this information is for you if: Your eye doctor has said that you have open-angle glaucoma,

More information

Release of the 2013/14 Invitation to Tender

Release of the 2013/14 Invitation to Tender 07 November 2013 Release of the 2013/14 Invitation to Tender The 2013/14 Invitation to Tender (2013/14 ITT) has been distributed today via the electronic tender (etender) system. If you do not receive

More information

Chronic eye diseases. Title of section divider. What s new, and how GPs can help. Eg. Case Study 1. Dr Jesse Gale, ophthalmologist

Chronic eye diseases. Title of section divider. What s new, and how GPs can help. Eg. Case Study 1. Dr Jesse Gale, ophthalmologist Chronic eye diseases Title of section divider What s new, and how GPs can help Eg. Case Study 1. Dr Jesse Gale, ophthalmologist 1 Title of section divider Cataract Eg. Case Study 1. 2 Cataract - what s

More information

Financial Disclosure. Prostaglandin Analogs (PGs) The Glaucoma Grab Bag: Practical Guidelines for Effective Glaucoma Therapy

Financial Disclosure. Prostaglandin Analogs (PGs) The Glaucoma Grab Bag: Practical Guidelines for Effective Glaucoma Therapy The Glaucoma Grab Bag: Practical Guidelines for Effective Glaucoma Therapy Danica J. Marrelli, OD, FAAO University of Houston College of Optometry Financial Disclosure I have received I have received speaking

More information

12.1 DRUGS ACTING ON THE EAR

12.1 DRUGS ACTING ON THE EAR 12.1 DRUGS ACTING ON THE EAR Anti-inflammatory/anti-infective preparations These preparations usually contain a corticosteroid either alone or with an antibacterial agent. Betamethasone 0.1% ear, eye,

More information

Optometrists Formulary. Compiled and produced by Professor John Lawrenson Division of Optometry and Visual Science City University London

Optometrists Formulary. Compiled and produced by Professor John Lawrenson Division of Optometry and Visual Science City University London Optometrists Formulary Compiled and produced by Professor John Lawrenson Division of Optometry and Visual Science City University London August 2016 Contents Optometrists formulary background notes 1 Acetazolamide

More information

PHARMACOLOGY FOR OPTOMETRY

PHARMACOLOGY FOR OPTOMETRY DEPARTMENT OF PHARMACOLOGY PHAR 3306 PHARMACOLOGY FOR OPTOMETRY COURSE OUTLINE Session 2, 2015 CRICOS Provider Code 00098G TABLE OF CONTENTS PHAR3306 Course Information... 3 Units of Credit (UOC)... 3

More information

Kentucky Department for Medicaid Services. Drug Review Options

Kentucky Department for Medicaid Services. Drug Review Options Kentucky Department for Medicaid Services Drug Review Options The following chart lists the agenda items scheduled and the options submitted for review at the March 18, 2010 meeting of the Pharmacy and

More information

The Trust does not record electronically the number of patients who are treated by laser for a condition.

The Trust does not record electronically the number of patients who are treated by laser for a condition. Ref: FOI/CAD/ID 3224 06 April 20 Please reply to: FOI Administrator Trust Management Maidstone Hospital Hermitage Lane Maidstone Kent ME 9QQ Email: mtw-tr.foiadmin@nhs.net Freedom of Information Act 2000

More information

Dry Eye Prescribing Guidelines

Dry Eye Prescribing Guidelines Dry Eye Prescribing Guidelines Amendment History VERSION DATE AMENDMENT HISTORY V1.0 2011 Comments V1.1 2013 Updated V1.1 2017 Draft Updated Thealoz Duo replaces carmellose Optive in severe dry eye on

More information

Ophthalmological preparations

Ophthalmological preparations Ophthalmological preparations Administration of eye preparations Preparations for the eye should be sterile when issued. Use of single-application containers is preferable; multiple-application preparations

More information

Supply should only occur if requesting signature is on approved list held by the issuing pharmacy

Supply should only occur if requesting signature is on approved list held by the issuing pharmacy Trust Approved Drugs List March 2016 The following is the list of drugs that are approved by the EEAST Medicines Management Group for use by EEAST clinical staff. Pharmacies are advised that this is the

More information

The healthiest place to live and work, by 2025

The healthiest place to live and work, by 2025 Quoracy 30/09/16 Cannock Chase Clinical Commissioning Group The healthiest place to live and work, by 2025 Joint CCG Formulary Working Group Friday 30 th September 2016 1.00pm 3.00pm Anglesey House, Rugeley,

More information

Ophthalmic Immunomodulators Prior Authorization with Quantity Limit Program Summary

Ophthalmic Immunomodulators Prior Authorization with Quantity Limit Program Summary Ophthalmic Immunomodulators Prior Authorization with Quantity Limit Program Summary FDA APPROVED INDICATIONS DOSAGE 1,4 Agent Indication Dosage and Administration Restasis (cyclosporine ophthalmic emulsion)

More information

Ocular Medication and Compliance

Ocular Medication and Compliance Ocular Medication and Compliance Consultant for Alcon Disclosures CECELIA KOETTING, OD FAAO VIRGINIA EYE CONSULTANTS VOA CONFERENCE NORFOLK 2018 Virginia Optometry License Generic vs Brand Name Every state

More information

Dry Eye Syndrome Prescribing Guidelines

Dry Eye Syndrome Prescribing Guidelines Dry Eye Syndrome Prescribing Guidelines Dry Eye Syndrome is a group of disorders of the ocular surface related to tear film abnormality, associated with ocular discomfort, visual symptoms and objective

More information

TA Number. TA Link. Annotation

TA Number. TA Link. Annotation Report generated from BNF provided by FormularyComplete (www.pharmpress.com). Accessed 16 02 2017 Title Formulary Status Section TA Number TA Link Annotation Anti-infective preparations Anti-inflammatory

More information

Pharmaceutical Management Medicaid 2019

Pharmaceutical Management Medicaid 2019 Pharmaceutical Management Medicaid 2019 Toll-free Contact Number: (888) 327-0671 Pharmacy Administration: (810) 244-1660 Introduction Pharmaceutical Management promotes the use of the most clinically appropriate,

More information

PHARMA-MEDIC SERVICES INC. POLICY MANUAL

PHARMA-MEDIC SERVICES INC. POLICY MANUAL PHARMA-MEDIC SERVICES INC. POLICY MANUAL SUBJECT: INDEX: P.5.a.iii Automatic-Therapeutic Substitution DATE: June 1/2011 REVISED: March 2, 2015., Feb 2017. PROCEDURE: 1. Long term care homes use the Manitoba

More information

July Formulary Policy

July Formulary Policy Formulary Policy July 2017 Responsible Committee: Quality Committee Date Effective: July 2017 Author: Rahinatu Amadu Supersedes: July 2016 Next Review Due: July 2018 Formulary Policy 2016-2018 1. INTRODUCTION

More information

Summary of the risk management plan (RMP) for Izba (travoprost)

Summary of the risk management plan (RMP) for Izba (travoprost) EMA/14138/2014 Summary of the risk management plan (RMP) for Izba (travoprost) This is a summary of the risk management plan (RMP) for Izba, which details the measures to be taken in order to ensure that

More information

IOP measurements: 8.00 am (trough drug levels) and am (peak drug levels)(2 hours post dose)

IOP measurements: 8.00 am (trough drug levels) and am (peak drug levels)(2 hours post dose) This overview of 2% eye drops was presented by Dr. Ravin N. Das, at Hotel Satya Ashoka, on 19-6-2004 in place of Dr. H. S. Ray due to unforseen circumstances. This dinner meeting was sponsored by Cipla

More information

Technology appraisal guidance Published: 16 December 2015 nice.org.uk/guidance/ta369

Technology appraisal guidance Published: 16 December 2015 nice.org.uk/guidance/ta369 Ciclosporin for treating dry eye e disease that has not improved despite treatment with artificial tears Technology appraisal guidance Published: 16 December 2015 nice.org.uk/guidance/ta369 NICE 2018.

More information

Get a grip on your glaucoma Booklet 1

Get a grip on your glaucoma Booklet 1 Information for Patients Glaucoma services Welcome! Get a grip on your glaucoma Booklet 1 Group-based Glaucoma information Course Session 1 What happens in session 1? Finding out what questions you have

More information

PRACTICAL APPROACH TO MEDICAL MANAGEMENT OF GLAUCOMA

PRACTICAL APPROACH TO MEDICAL MANAGEMENT OF GLAUCOMA PRACTICAL APPROACH TO MEDICAL MANAGEMENT OF GLAUCOMA DR. RAVI THOMAS, DR. RAJUL PARIKH, DR. SHEFALI PARIKH IJO MAY 2008 PRESENTER AT JDOS : DR. RAHUL SHUKLA T.N. SHUKLA EYE HOSPITAL TERMINOLOGY POAG: PRIMARY

More information

Administration and Supply of Emergency Medicines

Administration and Supply of Emergency Medicines APPENDIX WHO CAN GIVE WHAT? Administration and Supply of Emergency Clinician Authorisation Key to Exemptions from legislation: NPP Non Parenteral POM. Can be given according to a protocol. 7 HMR 0, Schedule

More information

Completed Clinical Research Trials Monte Dirks, M.D.

Completed Clinical Research Trials Monte Dirks, M.D. Completed Clinical Research Trials Monte Dirks, M.D. Monte Dirks, M.D. - Primary Investigator Norfloxacin -Merck (1986) Safety and efficacy of norfloxacin vs. tobramycin in the treatment of external ocular

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension 1.1 Short title Glaucoma 2 Background

More information

GREAT WESTERN HOSPITALS NHS FOUNDATION TRUST

GREAT WESTERN HOSPITALS NHS FOUNDATION TRUST Attendees: Dr Ravi Chinthapalli (RC) (chair) Katherine Watkinson () (mins) Dr Rachel Hobson (RH) Paul Clarke (PC) Lisa King (LK) Formulary Working Group 17 th October 2013 1400 1510 Liden Meeting Room,

More information

Glaucoma: diagnosis and management (large print version)

Glaucoma: diagnosis and management (large print version) Glaucoma: diagnosis and management (large print version) 1 November 2017 Recommendations People have the right to be involved in discussions and make informed decisions about their care, as described in

More information

Optometrists Formulary

Optometrists Formulary 1 Optometrists Formulary Compiled and Produced by Professor John Lawrenson, Division of Optometry and Visual Science City University London October 2012 2 Acetazolamide 9 Acetylcysteine 11 Aciclovir 13

More information

10 Musculoskeletal and Joint Diseases

10 Musculoskeletal and Joint Diseases 10 Musculoskeletal and Joint Diseases To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and British Society of Rheumatology guidelines and guidance

More information

APPLICATION TO INCLUDE A PROCEDURE, PHARMACEUTICAL OR OTHER DATA COLLECTION INSTRUMENT IN THE UNIVERSITY REGISTER

APPLICATION TO INCLUDE A PROCEDURE, PHARMACEUTICAL OR OTHER DATA COLLECTION INSTRUMENT IN THE UNIVERSITY REGISTER Revised 09/99 APPLICATION TO INCLUDE A PROCEDURE, PHARMACEUTICAL OR OTHER DATA COLLECTION INSTRUMENT IN THE UNIVERSITY REGISTER Copies of the questions and instructions can be viewed by moving your mouse

More information

Abbreviated Class Update: Ophthalmics, Glaucoma agents. Month/Year of Review: August 2012 End date of literature search: June 2012

Abbreviated Class Update: Ophthalmics, Glaucoma agents. Month/Year of Review: August 2012 End date of literature search: June 2012 Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

Pharmaceutical quality of reformulated bevacizumab as used in eye conditions in general.

Pharmaceutical quality of reformulated bevacizumab as used in eye conditions in general. The Royal College of Ophthalmologists 17 Cornwall Terrace, London. NW1 4QW. Telephone: 020-7935 0702 Facsimile: 020-7935 9838 Website: WWW.RCOPHTH.AC.UK PATRON HRH THE DUKE OF YORK, KG, KCVO, ADC The Royal

More information

Care homes - Homely remedies

Care homes - Homely remedies Bulletin 72 August 2014 Community Interest Company Care homes - Homely remedies Care home staff have a recognised duty of care to be able to respond to minor symptoms experienced by residents. A homely

More information

Drug Prescribing Pattern & Adverse Drug Effects Of Anti Glaucoma Medication for Primary Glaucoma at Tertiary Care Hospital

Drug Prescribing Pattern & Adverse Drug Effects Of Anti Glaucoma Medication for Primary Glaucoma at Tertiary Care Hospital IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 11 Ver. III (Nov. 2017), PP 36-41 www.iosrjournals.org Drug Prescribing Pattern & Adverse Drug

More information

Pharmacology of drugs acting on the eye. Prof. Hanan Hagar Pharmacology Unit College of Medicine

Pharmacology of drugs acting on the eye. Prof. Hanan Hagar Pharmacology Unit College of Medicine Pharmacology of drugs acting on the eye Prof. Hanan Hagar Pharmacology Unit College of Medicine ILOS Outline common routes of administration of drugs to the eye. Discuss the pharmacokinetics of drugs applied

More information

OHTS Baseline/Randomization Visit: BR

OHTS Baseline/Randomization Visit: BR Page 1 of 5 2/28/5 OHBR02.00 Coordinating Center use only Rec d... Log d... Chk d... Entr d... Checklist Check when completed Before exam, patient first completes SF-36 Quality of Life Before exam, patient

More information

Generics are Cheaper and Just as Effective

Generics are Cheaper and Just as Effective Disclosures Generics are Cheaper and Just as Effective Robert L. Stamper, MD UCSF Department of Ophthalmology No current pharmaceutical industry connections Data & Safety Monitor for Cypass - Chair - Transcend

More information

Serious Eye diseases, New treatments. Mr. M. Usman Saeed MBBS, FRCS, FRCOphth Consultant Ophthalmologist

Serious Eye diseases, New treatments. Mr. M. Usman Saeed MBBS, FRCS, FRCOphth Consultant Ophthalmologist Serious Eye diseases, New treatments Mr. M. Usman Saeed MBBS, FRCS, FRCOphth Consultant Ophthalmologist 5 major causes of loss of vision Cataracts Glaucoma Macular degeneration Retinal Vein occlusions

More information

Looking after Your Eyesight

Looking after Your Eyesight Slide 1 GORING AND WOODCOTE MEDICAL PRACTICE PATIENT PARTICIPATION GROUP (PPG) Open Meeting Looking after Your Eyesight 14 April 2018 Slide 2 Agenda The New Practice Website Julia Beasley Ophthalmology

More information

concentrate intravenous solution and other strong potassium solutions

concentrate intravenous solution and other strong potassium solutions Policy for the use of potassium chloride concentrate intravenous solution and other strong potassium solutions CLINICAL GUIDELINES ID TAG Policy for the use of potassium chloride Title: concentrate intravenous

More information

Volume 4; Number 6 May 2010

Volume 4; Number 6 May 2010 Volume 4; Number 6 May 2010 What s new this month: Local ophthalmologists have been working with PACEF to develop a formulary of eye preparations for the treatment of open angle and raised intra ocular

More information

Volume 4; Number 4 April 2010 PRESCRIBING GUIDANCE FOR HAY FEVER: SPRING / SUMMER 2010

Volume 4; Number 4 April 2010 PRESCRIBING GUIDANCE FOR HAY FEVER: SPRING / SUMMER 2010 Volume 4; Number 4 April 2010 PRESCRIBING GUIDANCE FOR HAY FEVER: SPRING / SUMMER 2010 PACEF Recommendations Recommended medicines remain the same as in recent years: Non-sedating antihistamines: generic

More information

Mild NPDR. Moderate NPDR. Severe NPDR

Mild NPDR. Moderate NPDR. Severe NPDR Diabetic retinopathy Diabetic retinopathy is the most common cause of blindness in adults aged 35-65 years-old. Hyperglycaemia is thought to cause increased retinal blood flow and abnormal metabolism in

More information

The use of eye drops and ointments in A&E

The use of eye drops and ointments in A&E Janet Marsden MSc, BSc (Hons), RGN, MIMgt is Senior Lecturer, Manchester Metropolitan University, and Chair of the RCN Ophthalmic Forum Janet Marsden describes the various eye drops and ointments commonly

More information

Allergies Formulary

Allergies Formulary Self-care should be encouraged as. Self Care The self care forum states: Empowering people with the confidence information to look after themselves when they can, visit the GP when they need to, gives

More information

Volume 9; Number 3 March 2015 PRESCRIBING AND DISPENSING PREGABALIN FOR NEUROPATHIC PAIN

Volume 9; Number 3 March 2015 PRESCRIBING AND DISPENSING PREGABALIN FOR NEUROPATHIC PAIN Arden and Greater East Midlands Commissioning Support Unit in association with Lincolnshire Clinical Commissioning Groups, Lincolnshire Community Health Services, United Lincolnshire Hospitals Trust and

More information

LIST OF MEDICINE FOR OUTPATIENT DEPARTMENT (O.P.D) S. No.

LIST OF MEDICINE FOR OUTPATIENT DEPARTMENT (O.P.D) S. No. Category C LIST OF MEDICINE FOR OUTPATIENT DEPARTMENT (O.P.D) S. 01 Dexamethasone +Chloramphenicol Eye drop 30000 02. 10000 Tobramycin 0.3% eye drop 03. Moxifloxacin Eye drop 7200 04. Hydroxypropyl Methyl

More information

Allergan s Blephamide (sulfacetamide/prednisolone ophthalmic ointment) 10%/0.2%, 3.5Gm tube

Allergan s Blephamide (sulfacetamide/prednisolone ophthalmic ointment) 10%/0.2%, 3.5Gm tube Allergan s Blephamide (sulfacetamide/prednisolone ophthalmic ointment) 10%/0.2%, 3.5Gm tube On Aug. 24, 2015, Allergan recalled three lots (86258 expires September 2017, 87189 December 2017 and 87514 February

More information

POLICY FOR THE SAFE USE OF ORAL METHOTREXATE IN SECONDARY CARE. September 2011

POLICY FOR THE SAFE USE OF ORAL METHOTREXATE IN SECONDARY CARE. September 2011 POLICY FOR THE SAFE USE OF ORAL METHOTREXATE IN SECONDARY CARE September 2011 WHSCT Policy for the safe use of oral methotrexate in secondary care Page 1 of 8 Policy Title Policy for the safe use of oral

More information

Summary of Main Points from the Meeting held on Monday 11 th September 2017

Summary of Main Points from the Meeting held on Monday 11 th September 2017 Summary of Main Points from the Meeting held on Monday 11 th September 2017 2. Minutes and Summary Notes from last meeting The Minutes and Summary notes from the July 2017 Medicines Group meeting were

More information

Update on management of Anterior Uveitis

Update on management of Anterior Uveitis Update on management of Anterior Uveitis Parthopratim Dutta Majumder Senior Consultant, Department of Uvea & Intraocular Inflammation Medical Research Foundation, Sankara Nethralaya ABCD of Treating a

More information

National Institute for Health and Clinical Excellence. Glaucoma. Guideline Consultation Comments Table. 29 September November 2008

National Institute for Health and Clinical Excellence. Glaucoma. Guideline Consultation Comments Table. 29 September November 2008 National Institute for Health and Clinical Excellence Glaucoma Guideline Consultation Comments Table 29 September 2008 24 November 2008 Stat us Organisa tion Order no. Version Page no Line no/se ction

More information

Document ref. no: Trust Policy and Procedure. PP(16)234 Prescribing, Dispensing and Administration of Methotrexate Policy

Document ref. no: Trust Policy and Procedure. PP(16)234 Prescribing, Dispensing and Administration of Methotrexate Policy Document ref. no: Trust Policy and Procedure PP(16)234 Prescribing, Dispensing and Administration of Methotrexate Policy For use in: For use by: For use for: Document owner: Status: All Clinical Areas

More information